Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Unsupervised machine learning identifies early stage breast cancer subclasses from aberrant glycogene expression and informs personalised drug treatment.

Created on 16 Nov 2026

Authors

Mia Venter, Kevin J Naidoo

Published in

Discover chemistry. Volume 3. Issue 1. Pages 630. Epub Nov 14, 2026.

Abstract

Unsupervised hierarchical clustering of early-stage breast cancer glycogene expression data using the Growing Hierarchical Self Organising Representation Map (GHSORM) algorithm identified seven subclasses. These glycogene expression clusters (GECs) overlap with known breast cancer biomarkers such as hormone receptor status and immune signatures. Feature discovery via Recursive Feature Elimination with Strikeout (RFES) identified a panel of 60 glycogenes that can predict GECs on an independent testing set with 90.48% accuracy. GEC-based subtyping of patients from the I-SPY2 clinical trial revealed an 86% pathologic complete response (pCR), demonstrating how glycogene expression in combination with custom machine learning algorithms could be an approach to molecular cancer diagnosis capable of informing personalised drug treatment.
The online version contains supplementary material available at https://doi.org/10.1007/s44371-026-01070-0.

PMID:
43036323
Bibliographic data and abstract were imported from PubMed on 16 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement